美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

VanEck Biotech ETF

231.17

+0.46970.20%

盤前：231.03-0.1434-0.06%08:23 EDT

成交量：3,421

成交額：79.19萬

市值：4.64億

市盈率：- -

高：231.68

開：231.68

低：231.17

收：230.70

52周最高：244.35

52周最低：160.91

股本：200.65萬

流通股本：200.65萬

量比：0.42

換手率：0.17%

股息：0.95

股息率：0.41%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費

Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段

Assembly Biosciences：吉利德獨享HSV HPI項目臨床開發與商業化權利

Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權

安進股價或創二十餘年來最大單日跌幅

福泰製藥(VRTX)股票9月8日盤中下跌3.06%：投資者必看的核心信息

TradingKey中文

吉利德科學(GILD)股票9月8日盤中下跌3.26%：釋放什麼信號？

TradingKey中文

諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌

安進(AMGN)股票9月8日盤中下跌8.33%：真相來了

TradingKey中文

BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華

更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期

安進股價下跌7%，創下自2025年6月以來最大單日跌幅。

更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標

安進Phase 3 Dellphi-305研究重大突破：總生存期獲益顯著優於度伐利尤單抗單藥治療

Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善

BMO下調安進及BioNTech評級至「與大市同步」

美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾

老虎资讯综合

諾華試驗受挫且BMO下調評級，安進股價下跌

盤前異動：安進、耐克、Bloom Energy 等個股受關注

美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/BBH/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":231.1734,"timestamp":1789588800000,"preClose":230.7037,"halted":0,"volume":3421,"hourTrading":{"tag":"盘前","latestPrice":231.03,"preClose":231.1734,"latestTime":"08:23 EDT","volume":31,"amount":7162.073219999999,"timestamp":1789647809022,"change":-0.1434,"changeRate":-0.00062,"amplitude":0.00062},"delay":0,"changeRate":0.002035944807127016,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"盤前交易","change":0.4697,"latestTime":"09-17 09:27:16 EDT","open":231.68,"high":231.68,"low":231.1734,"amount":791940.974,"amplitude":0.002196,"askPrice":265.51,"askSize":100,"bidPrice":199.58,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":231.1734,"sharesOutstanding":1976503,"nav":230.79718,"aum":463095224.42,"dividendRate":0.0041,"bidAskSpread":0.001036,"preHourTrading":{"tag":"盘前","latestPrice":231.03,"preClose":231.1734,"latestTime":"08:23 EDT","volume":31,"amount":7162.073219999999,"timestamp":1789647809022,"change":-0.1434,"changeRate":-0.00062,"amplitude":0.00062},"postHourTrading":{"tag":"盘后","latestPrice":231.35,"preClose":231.1734,"latestTime":"19:30 EDT","volume":14,"amount":3236.4276,"timestamp":1789601405727,"change":0.1766,"changeRate":0.000764,"amplitude":0},"volumeRatio":0.4224604161320307,"impliedVol":0.1729,"impliedVolPercentile":0.24},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4224604161320307,"shares":2006503,"dividePrice":0.9478,"high":231.68,"amplitude":0.002196,"preClose":230.7037,"low":231.1734,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":231.1734,"eps":0,"divideRate":0.0041,"volume":3421,"delay":0,"ttmEps":0,"open":231.68,"prevYearClose":189.2649,"fiveDayClose":231.22,"twentyDayClose":224.4799,"sixtyDayClose":189.3704},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1136308873","title":"Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1136308873","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136308873?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897732,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前披露，其在海外市场具备资格获取最高达2.8亿美元的里程碑款项，外加相应特许权使用费收入。据悉，这家生物科技企业所预期的资金流入将源自美国以外地区。对Assembly Biosciences而言，这笔潜在收入不仅反映其管线资产的外部合作价值，也可能为其后续研发投入提供坚实支撑。市场人士认为，此类非美国市场的收益结构有助于分散地域风险，增强公司财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","LU0965509283.SGD","IE00B7SZLL34.SGD","IBB","LU1585245621.USD","IE00B3T34201.USD","MEDI","BMED","LU0234570918.USD","LU1037948897.HKD","LU2089984988.USD","TMED","LU0289739699.SGD","LU1430594728.SGD","LU2087621335.USD","BK4588","LU2468319806.SGD","LU1778281490.HKD","SG9999015952.SGD","LU1037948541.HKD","SG9999015986.USD","ASMB","LU0122379950.USD","BK4583","BK4585","IE00BKVL7J92.USD","BK4532","BK4139","BBH","LU2112291526.USD","BIB","TBXU","LU0823416689.USD","LU1066051498.USD","LU0058720904.USD","IE00BSNM7G36.USD","LU0109394709.USD","LU1934455863.HKD","SG9999015978.USD","IBBQ","LU0965508806.USD","LU2324357040.USD","BK4550","BK4568","LU0965509101.SGD","IE00BZ1G4Q59.USD","SG9999015945.SGD","LU1674673691.USD","BK4578","LU0861579265.USD","IE0002270589.USD","LU1061106388.HKD","IE00B19Z3581.USD","LU0889565916.HKD","LU1066053197.SGD","LU0859254822.USD","LU1934455194.USD","LU2357627491.SGD","LU1023059063.AUD","LU1674673428.USD","LU0114720955.EUR","BK4566","LU0965509010.AUD","LU1934455277.USD","LU0882574055.USD","GILD","LU1571399168.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154623157","title":"Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623157","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154623157?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897731,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前宣布，其研发管线中的候选药物Gs-1179有望在2026年年底之前顺利迈入针对生殖器疱疹的二期临床试验阶段。生殖器疱疹作为一种常见的性传播感染疾病，全球患者群体庞大，对创新疗法的需求十分迫切。Assembly Biosciences正积极加速该药物的研发进程，以期尽早为患者带来新的治疗选择。业内分析人士指出，若Gs-1179能够顺利通过后续试验的严格考验，将可能重塑该适应症的市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU2087621335.USD","LU1839511570.USD","BK4578","LU0289739699.SGD","IE00B19Z3B42.SGD","IBB","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0882574055.USD","LU0058720904.USD","BMED","LU1585245621.USD","LU2112291526.USD","TMED","LU0859254822.USD","SG9999015978.USD","LU1066051498.USD","LU0965509010.AUD","LU1934455194.USD","GILD","LU0889565916.HKD","SG9999015986.USD","LU1061106388.HKD","LU0114720955.EUR","LU1934455863.HKD","LU1037948541.HKD","LU0320765992.SGD","BK4566","BK4550","BK4568","LU0861579265.USD","LU1674673691.USD","LU1023059063.AUD","SG9999015945.SGD","LU1057294990.SGD","SG9999015952.SGD","IBBQ","BIB","LU2357627491.SGD","LU1934455277.USD","TBXU","IE00B19Z3581.USD","LU0965509283.SGD","BK4532","LU0965508806.USD","LU1430594728.SGD","IE0002270589.USD","LU0109394709.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU2089984988.USD","BK4585","LU0234570918.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU1674673428.USD","BK4139","BK4583","ASMB","IE00BSNM7G36.USD","MEDI","LU2468319806.SGD","LU0122379950.USD","LU0823416689.USD","LU2324357040.USD","BK4588","LU1037948897.HKD","LU0965509101.SGD","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115029168","title":"Assembly Biosciences：吉利德獨享HSV HPI項目臨床開發與商業化權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1115029168","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115029168?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897702,"startTime":"0","endTime":"0","summary":"Assembly Biosciences宣布，吉利德科学已保留其HSV HPI项目的独家临床开发及商业化权利。这一决定标志着双方合作进一步深化，吉利德将全权主导该项目的后续推进与市场布局。对于Assembly Biosciences而言，此举不仅明确了合作伙伴的战略优先级，也为其自身聚焦其他管线资源提供了更大灵活性。业内观察人士指出，HSV HPI项目的独家授权，反映了吉利德在抗病毒治疗领域持续加码的雄心，同时也凸显了该类创新疗法在未被满足的医疗需求中所蕴含的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","LU0109394709.USD","IBB","BK4139","LU0859254822.USD","LU2468319806.SGD","TBXU","IE00B19Z3B42.SGD","BK4532","LU0320765992.SGD","LU1839511570.USD","LU2112291526.USD","MEDI","IE0002270589.USD","BK4566","LU0114720955.EUR","IE00BSNM7G36.USD","LU0823416689.USD","LU1430594728.SGD","LU2089984988.USD","LU1934455194.USD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU1037948541.HKD","LU1585245621.USD","SG9999015945.SGD","LU0122379950.USD","LU1778281490.HKD","GILD","IE00B7SZLL34.SGD","BIB","LU2357627491.SGD","LU0965509101.SGD","LU0861579265.USD","LU0965508806.USD","SG9999015978.USD","LU2324357040.USD","LU1571399168.USD","LU1934455277.USD","LU1037948897.HKD","BK4588","SG9999015952.SGD","LU1061106388.HKD","LU1934455863.HKD","BK4583","LU2087621335.USD","BMED","BK4550","IBBQ","LU0058720904.USD","LU0234570918.USD","LU0965509283.SGD","BK4585","TMED","IE00BKVL7J92.USD","ASMB","LU0882574055.USD","LU0889565916.HKD","LU1023059063.AUD","IE00B19Z3581.USD","IE00B3T34201.USD","LU1066051498.USD","BK4568","LU1674673691.USD","SG9999015986.USD","BBH","LU1066053197.SGD","LU1057294990.SGD","LU0289739699.SGD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179230759","title":"Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權","url":"https://stock-news.laohu8.com/highlight/detail?id=1179230759","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179230759?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897669,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司已正式行使与吉利德科学就HSV解旋酶-引物酶抑制剂项目达成的美国利润分成选择权。这一战略举措标志着双方合作进入新阶段，有望加速该抗病毒疗法的临床开发与商业化进程。通过行使该选择权，Assembly Biosciences将能够分享该药物在美国市场的未来收益，同时借助吉利德在抗病毒领域的深厚积累与市场渠道，共同推进这一潜在重磅药物的落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU0289739699.SGD","SG9999015945.SGD","IE00B3T34201.USD","BIB","LU0109394709.USD","LU1057294990.SGD","LU1778281490.HKD","LU2324357040.USD","BK4588","LU1061106388.HKD","ASMB","LU0889565916.HKD","LU1674673691.USD","LU0320765992.SGD","LU1839511570.USD","BK4139","LU0234570918.USD","BMED","LU0122379950.USD","LU2087621335.USD","LU0965509101.SGD","IE0002270589.USD","LU1066053197.SGD","BK4585","SG9999015978.USD","SG9999015986.USD","LU0859254822.USD","LU0861579265.USD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU2468319806.SGD","LU0058720904.USD","LU0882574055.USD","LU1934455863.HKD","LU0114720955.EUR","IE00BSNM7G36.USD","MEDI","TMED","LU0965509283.SGD","LU1066051498.USD","LU1934455277.USD","BK4532","IE00B19Z3581.USD","BK4568","IBB","LU0965508806.USD","LU1585245621.USD","TBXU","LU1037948541.HKD","LU1674673428.USD","LU1037948897.HKD","IBBQ","BBH","BK4578","LU2089984988.USD","LU2112291526.USD","BK4550","GILD","BK4566","LU2357627491.SGD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU1934455194.USD","LU1571399168.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU1023059063.AUD","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111756325","title":"安進股價或創二十餘年來最大單日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1111756325","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111756325?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:23","pubTimestamp":1788891793,"startTime":"0","endTime":"0","summary":"安进公司股价近期重挫逾9%，这一跌幅令这家生物技术巨头有望迎来自2000年10月以来最惨淡的单日表现。此番暴跌的导火索，源于诺华制药宣布其心脏病药物pelacarsen在降低心血管事件风险方面未能优于安慰剂，试验宣告失败。周二，礼来股价小幅下挫1.9%。安进的跌势因BMO资本市场的下调评级而进一步加剧，使其沦为标普500指数和纳斯达克100指数中的最大输家。","market":"hk","thumbnail":"https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","IBBQ","LU0122379950.USD","LU1571399168.USD","LU0889565916.HKD","AMGN","PJP","BK4533","BK4599","IE0009355771.USD","SG9999001440.SGD","LU0289739699.SGD","LU2242652126.USD","BK4566","IBB","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4534","LU2089984988.USD","BIB","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","04332","BK4139","LU0109394709.USD","LU0320765992.SGD","BK4585","PBE","LU0058720904.USD","LU2468319806.SGD","LU1061106388.HKD","BK4588","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1983299246.USD","BBH","LU2242646821.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374214","title":"福泰製藥(VRTX)股票9月8日盤中下跌3.06%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374214","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374214?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:16","pubTimestamp":1788891392,"startTime":"0","endTime":"0","summary":"• Vertex 股价在反弹至接近52周高点后遭遇波动与获利回吐。\n• 对 Crinetics 的收购整合要到2029年才能实现非GAAP增盈。\n• 技术指标显示 MACD 呈中性，RSI 呈中性，威廉指标（Williams %R）呈超卖状态。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156640-market-movers-vrtx-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1778281490.HKD","IBBQ","LU2362541273.HKD","IE00B19Z3581.USD","LU0432979614.USD","LU2362540622.SGD","SG9999001176.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","SG9999001176.SGD","LU0079474960.USD","VRTX","IE0009355771.USD","LU0256863811.USD","GNMX","LU1674673428.USD","LU2362541513.USD","LU1674673691.USD","BK4588","IDNA","LU1093756325.SGD","TBXU","BK4139","LU0061475181.USD","LU1093756168.USD","PBE","SGXZ57979304.SGD","IBB","IE00B19Z9Z06.USD","IE00B2B36J28.USD","SG9999013999.USD","BIB","LU0234570918.USD","IE0002141913.USD","LU1035775433.USD","LU1069344957.HKD","BK4585","LU0289739699.SGD","BK4532","LU2237438978.USD","BK4533","LU1430594728.SGD","BBH","LU1585245621.USD","IE0002270589.USD","LU0417517546.SGD","LU2417539215.USD","IE00B894F039.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374570","title":"吉利德科學(GILD)股票9月8日盤中下跌3.26%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374570","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374570?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 01:16","pubTimestamp":1788887780,"startTime":"0","endTime":"0","summary":"• 吉利德在经历了长达数月的持续上涨后，因获利回吐而出现回调。\n• 强劲的第二季度营收主要受其旗舰 HIV 和 Trodelvy 产品线的推动。\n• 分析师维持“买入”评级，平均目标价为 157.79 美元。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156554-market-movers-gild-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","IBB","LU1023059063.AUD","BK4578","LU0859254822.USD","SG9999015978.USD","IE00B19Z3B42.SGD","BK4568","TBXU","LU2112291526.USD","LU0823416689.USD","LU0320765992.SGD","BBH","LU0114720955.EUR","LU1778281490.HKD","IE00BKVL7J92.USD","GILD","LU1430594728.SGD","IE00BZ1G4Q59.USD","BK4532","LU0109394709.USD","IBBQ","LU1674673428.USD","IE00B19Z3581.USD","IE0002270589.USD","LU2087621335.USD","SG9999015952.SGD","LU0289739699.SGD","LU0965508806.USD","LU1037948541.HKD","MEDI","BIB","LU2324357040.USD","BK4585","SG9999015945.SGD","LU0965509101.SGD","SG9999015986.USD","IE00B3T34201.USD","LU0122379950.USD","LU0058720904.USD","LU1934455277.USD","LU1674673691.USD","LU0882574055.USD","LU0861579265.USD","LU1839511570.USD","BK4583","LU1571399168.USD","BMED","TMED","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371445","title":"諾華公司一款降膽固醇藥物在臨床試驗中失敗，Royalty Pharma股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371445","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371445?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 00:41","pubTimestamp":1788885660,"startTime":"0","endTime":"0","summary":"——Royalty Pharma** RPRX重申“其2030年投资组合收入目标为47亿美元或更高”** 计入本交易日涨幅，该股今年以来累计上涨54.7%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4501DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","TBXU","BBH","BK4588","LU2112291526.USD","BK4533","BK4566","AMGN","BK4585","IBBQ","BIB","RPRX","PBE","LU1571399168.USD","LU1983299246.USD","LU0289739699.SGD","BK4534","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","LU0058720904.USD","LU1057294990.SGD","BK4007","LU0320765992.SGD","PJP","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","LU0889565916.HKD","IE0009355771.USD","BK4581","IE0002141913.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00B2B36J28.USD","LU2242652126.USD","IONS","IE00BFTCPJ56.SGD","BK4599","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376637","title":"安進(AMGN)股票9月8日盤中下跌8.33%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376637","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376637?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 22:16","pubTimestamp":1788876978,"startTime":"0","endTime":"0","summary":"• 诺华 pelacarsen 试验失败，加大了安进竞品 olpasiran 的临床不确定性。\n• 出于对估值的担忧，BMO Capital 将安进的评级从“跑赢大盘”下调至“与大盘持平”。\n• 技术指标显示，安进的 RSI 为 40.256，威廉指标（Williams %R）为 97.857。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156239-market-movers-amgn-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU0109394709.USD","LU0058720904.USD","LU2242652126.USD","SG9999001440.SGD","PJP","IBB","BK4566","LU2112291526.USD","BK4139","LU2242646821.SGD","BK4599","LU1023059063.AUD","BK4533","LU0320765992.SGD","LU1983299246.USD","PBE","LU0889565916.HKD","BIB","TBXU","LU0289739699.SGD","LU1061106388.HKD","BK4534","AMGN","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU2468319806.SGD","IBBQ","BBH","BK4588","IE0009355771.USD","LU0868494617.USD","LU1571399168.USD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4581","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1057294990.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375206","title":"BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875887,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Sigma Lithium、Shake Shack、诺华工作区中用于查询单只股票行情的搜索字符串：STXBZ《今日展望》通讯：https://refini.tv/3LI4BU7《晨间新闻简报》：https://refini.tv/3dKUyB8路透9月8日-周二开盘时，华尔街主要股指涨跌不一，中东地区新一轮冲突推动油价升至7月下旬以来的最高水平，而市场正在等待本周晚些时候","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S45014M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","FRNW","LU0345769128.USD","BK4168","LU0878866978.SGD","SGXZ57979304.SGD","LU1303367103.USD","BK4592","BK4504","LU0456855351.SGD","LU1153585028.USD","LU2543165471.USD","LU0138981039.USD","LU1894683348.USD","LU2506952170.USD","BK4602","LU0234572021.USD","BK4591","LU2249611893.SGD","LU2244417387.USD","BK4581","LU0823414478.USD","BK4209","LU1718418525.SGD","BK4182","LU0289739699.SGD","LU2265009873.SGD","LU2357125470.USD","USNG","LU2098885051.SGD","IE0031619046.USD","RGTZ","PJP","LU1883839398.USD","LU0029874061.USD","SEI","LU1064131342.USD","ABM","LU2491050071.SGD","LU0345769631.USD","NVS","LU0170899867.USD","VTWG","LU2506951958.HKD","WATS","SMOG","LU1066053197.SGD","LU1023059063.AUD","LU0077335932.USD","ZAP","ILMN","LU2112291526.USD","OIH","IBB","LU0225283273.USD","LU0306807586.USD","IE00B19Z3581.USD","LU2087625088.SGD","IONS","LU0109394709.USD","CHRW","BK4131","LU1366192091.USD","IE0009354923.USD","ALV","IE00BJJMRZ35.SGD","IBAT","LU0225771236.USD","BK4588","LU1720051108.HKD","LU0353189763.USD","LU0444971666.USD","LU1093756325.SGD","LU2506951792.HKD","SG9999002224.SGD","IE00BLSP4239.USD","RGTX","LU0058720904.USD","LU0353189680.USD","LU1989772923.USD","BEX","LU1057294990.SGD","IE00B19Z3B42.SGD","LU1989771016.USD","IE00B2B36J28.USD","BK4124","LU1791710400.SGD","MEDX","LU2362540622.SGD","LU0128526141.USD","LU1642822529.SGD","LU0823414551.USD","IOYY","LU0889565916.HKD","LU0985481810.HKD","PHVS","BEG","BK4007","LU0306806265.USD","IE00B7SZL793.SGD","LU0823417653.USD","EGGY","SIMS","LU0187121727.USD","BK4170","LU0882574055.USD","LU1989764664.SGD","VCLN","BIB","LU1815336760.USD","LU2362541513.USD","IONL","BBH","LU0208291251.USD","BK4121","LU0950375773.USD","LU1988902786.USD","IE000M9KFDE8.USD","BK4179","LU2506951875.HKD","LU2362541273.HKD","LU0048584097.USD","LU0114720955.EUR","UNFI","IE00B66KJ199.SGD","IONC","LU0320765489.SGD","LU0528227936.USD","BK4532","AMGN","LU0211331839.USD","SG9999001440.SGD","LU1989772840.SGD","PTH","IBBQ","BK4541","LU0070302665.USD","BK4556","BHVN","LU0433182093.SGD","BK4597","RGTI","LU1894683264.USD","BK4505","NTLA","HYDR","BK4535","PFE","BK4120","LU1989764748.USD","SG9999003800.SGD","LU1804176565.USD","LU0444973449.USD","ICLN","PPH","WQTM","BK4141","LU0432979614.USD","SGML","LU1291159041.SGD","IE00B3T34201.USD","LU2242652126.USD","BK4568","CTEC","LU0251132253.USD","IE0002141913.USD","IE00BJT1NW94.SGD","BK4567","OZEM","DYN","IONX","BEZ","LU2294711713.HKD","BE","LU0122379950.USD","LU2357305700.SGD","SG9999011175.SGD","LU2264538146.SGD","LU2491050154.USD","LU0321505439.SGD","LU0823416689.USD","BK4102","CNRG","LU1861558580.USD","IE0034235188.USD","LU1878469433.USD","SG9999001176.SGD","UPGR","BK4139","LU0868494617.USD","LU0068578508.USD","LU1720051017.SGD","RGTC","BEC","IE00B19Z4B17.USD","LU0320765992.SGD","LU2242649171.HKD","LU0011850046.USD","SG9999001176.USD","LU0321505868.SGD","LU1093756168.USD","BK4082","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU1489326972.SGD","LU2089984988.USD","LU2491049909.HKD","PBE","SG9999013999.USD","LU2596442595.SGD","LU0823417737.USD","LU2324357040.USD","BK4578","LU2468319806.SGD","BK4550","LU0225284248.USD","LU0985489474.SGD","QTUP","XES","IE00B4R5TH58.HKD","LU1548497426.USD","GNMX","RGYY","LU1861559042.SGD","SHAK","BK4548","RGTU","BK4566","IONQ","LU0266013472.USD","SG9999002232.USD","BK4533","LU1571399168.USD","LU0267386448.USD","BK4585","IE0009355771.USD","LU0238689110.USD","ROIV","LU1983299246.USD","TBXU","IE00BBT3K403.USD","IE0002270589.USD","BK4534","LU2242646821.SGD","LU0476273544.USD","GNOM","04332","IONZ","LU1791710582.SGD","LU2506952097.USD","CQTM","SRPU","BSX","LU1066051498.USD","IE00BLSP4452.SGD","LU0957808578.USD","SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665251375","title":"更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=2665251375","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665251375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:52","pubTimestamp":1788875520,"startTime":"0","endTime":"0","summary":"更新版 1-阿斯利康的联合用药方案在晚期研究中帮助肺癌患者延长了生存期全文补充了有关临床试验和背景的详细信息路透9月8日-阿斯利康AZN.L周二表示，其抗癌药物Imfinzi与安进的AMGN.O靶向免疫疗法Imdelltra联合使用，在一项晚期临床试验中显著提高了广泛期小细胞肺癌患者的总生存期。癌症治疗药物占阿斯利康销售额近一半；2025年，在该公司256.2亿美元的肿瘤产品收入中，Imfinzi贡献了60.6亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T45013T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU0171293334.USD","BIB","LU1046234339.USD","LU0058720904.USD","LU1273509221.SGD","LU0557290698.USD","LU0887340254.USD","IBB","LU0029864427.USD","BBH","IE0009355771.USD","LU2108987350.USD","AZN.UK","LU0211328371.USD","LU0997586432.USD","LU2279689827.SGD","LU1989771016.USD","LU0158827948.USD","IE00B3T34201.USD","LU0708994859.HKD","LU1267930490.SGD","LU2089284900.SGD","BK4588","LU0889566641.SGD","LU0969580561.USD","LU1196032939.SGD","BK4585","LU0784384876.USD","LU2237443622.USD","LU2242646821.SGD","LU1153585028.USD","LU0211327993.USD","IBBQ","BK4533","PBE","AMGN","LU1267930813.SGD","LU0289739699.SGD","TBXU","LU0211326755.USD","LU0553294199.USD","LU2468319806.SGD","03165","LU0738911758.USD","PJP","LU1267930227.SGD","LU2125909593.SGD","LU0792757196.USD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375527","title":"安進股價下跌7%，創下自2025年6月以來最大單日跌幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375527?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:30","pubTimestamp":1788874246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1023059063.AUD","IBBQ","AMGN","LU0889565916.HKD","BK4588","LU0320765992.SGD","IBB","LU0868494617.USD","LU0058720904.USD","BK4139","PBE","BK4533","BIB","IE0002141913.USD","IE00B4R5TH58.HKD","LU1983299246.USD","IE0009355771.USD","BK4566","LU0109394709.USD","BK4581","SG9999001440.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2242646821.SGD","LU2468319806.SGD","PJP","LU1571399168.USD","TBXU","BBH","LU2242652126.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4599","LU2112291526.USD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665732793","title":"更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665732793","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665732793?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:14","pubTimestamp":1788873260,"startTime":"0","endTime":"0","summary":"阿斯利康抗癌药物组合在晚期临床试验中达到主要生存目标路透9月8日-阿斯利康（AstraZeneca）AZN.L周二表示，其抗癌药物Imfinzi与安进（Amgen）的AMGN.O靶向免疫疗法Imdelltra联合使用，在一项晚期临床试验中，显著提高了广泛期小细胞肺癌一线治疗患者的总生存期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S450114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","BK4599","LU0997586515.USD","LU2237443465.HKD","LU0029864427.USD","LU0920783379.SGD","AZN.UK","BK4139","LU0058720904.USD","LU0122379950.USD","LU1863844749.USD","LU2091194634.USD","LU1084165304.USD","IBBQ","BIB","LU0545039389.USD","LU1487256676.USD","LU1829250122.USD","IBB","IE0034235188.USD","LU0957799991.USD","LU1061106388.HKD","LU0077335932.USD","LU1003076772.USD","LU0526926950.USD","LU1880407132.USD","AMGN","LU0969580561.USD","LU0203347892.USD","PBE","LU1023059063.AUD","TBXU","LU0109394709.USD","03165","LU0784383803.USD","LU0868494617.USD","LU0289739699.SGD","LU1046234339.USD","PJP","LU2279689827.SGD","LU2355687059.USD","LU0889566641.SGD","LU2433249047.HKD","LU1170363599.USD","LU0827474353.SGD","LU2242652126.USD","LU1923622614.USD","LU1481599808.USD","BBH","LU0661504455.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115495471","title":"安進Phase 3 Dellphi-305研究重大突破：總生存期獲益顯著優於度伐利尤單抗單藥治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1115495471","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115495471?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:07","pubTimestamp":1788872830,"startTime":"0","endTime":"0","summary":"安进公司宣布，其Phase 3 Dellphi-305临床研究取得重大成果——与度伐利尤单抗单独用药相比，该疗法在总生存期上展现出显著且具有临床意义的改善。这一里程碑式的发现，无疑为肿瘤治疗领域注入了新的活力与希望。尽管完整的详细数据尚未全面披露，但安进方面表示，其临床意义及安全性特征将在即将召开的重大学术会议上进行详尽报告。安进公司并未止步于此。随着研发管线的持续推进，安进正逐步兑现其以创新疗法攻克严重疾病的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0058720904.USD","LU2112291526.USD","LU0289739699.SGD","LU0868494617.USD","IBBQ","IE00BJT1NW94.SGD","LU2468319806.SGD","PBE","BK4588","LU0122379950.USD","TBXU","IE00B4R5TH58.HKD","AMGN","IE00B2B36J28.USD","LU0109394709.USD","LU1571399168.USD","LU1061106388.HKD","IE0002141913.USD","SG9999001440.SGD","LU1057294990.SGD","BK4585","IE00BFTCPJ56.SGD","IBB","BK4533","BIB","BK4599","IE0009355771.USD","LU1023059063.AUD","LU2242646821.SGD","BBH","LU2089984988.USD","LU1983299246.USD","BK4581","LU0889565916.HKD","BK4534","LU2242652126.USD","LU0320765992.SGD","BK4566","PJP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109517247","title":"Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1109517247","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109517247?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:04","pubTimestamp":1788872687,"startTime":"0","endTime":"0","summary":"Imdelltra®与Imfinzi®的联合疗法，于一线广泛期小细胞肺癌治疗领域，取得了具有划时代意义的总生存期提升。这一突破性进展，不仅为患者带来了新的曙光，也重塑了该领域的治疗格局。从数据层面观察，联合治疗方案的生存获益尤为显著，堪称里程碑式的成就。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BJJMRZ35.SGD","IE0009355771.USD","LU1061106388.HKD","LU1571399168.USD","LU1023059063.AUD","LU0122379950.USD","BK4585","BBH","BK4534","LU0109394709.USD","LU0289739699.SGD","LU0868494617.USD","LU2468319806.SGD","LU2242646821.SGD","IBB","LU2242652126.USD","LU1983299246.USD","LU1057294990.SGD","BK4533","PBE","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BIB","LU0058720904.USD","BK4599","AMGN","TBXU","IE00BFTCPJ56.SGD","LU2112291526.USD","BK4566","LU2089984988.USD","BK4581","LU0320765992.SGD","LU0889565916.HKD","SG9999001440.SGD","PJP","IBBQ","BK4588","IE0002141913.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387373","title":"BMO下調安進及BioNTech評級至「與大市同步」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665387373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:59","pubTimestamp":1788872377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BIB","AMGN","LU1061106388.HKD","LU2242646821.SGD","BK4566","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU1023059063.AUD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2468319806.SGD","IBB","BK4533","LU0122379950.USD","IE00B2B36J28.USD","BK4139","LU0868494617.USD","LU1983299246.USD","BK4588","LU2112291526.USD","IE0002141913.USD","LU2242652126.USD","BBH","IBBQ","BK4581","IE0009355771.USD","LU1057294990.SGD","LU1571399168.USD","PJP","LU0289739699.SGD","SG9999001440.SGD","LU0320765992.SGD","BK4534","LU2089984988.USD","PBE","LU0109394709.USD","BK4599","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103332998","title":"美股盤前｜英特爾、甲骨文升逾4%；諾華重挫12%，IONIS下跌10%；阿斯麥新一代EUV光刻機獲台積電和三星使用承諾","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103332998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868860,"startTime":"0","endTime":"0","summary":"9月8日美元指数上升0.0364%，报98.96。03 要闻1. 三大芯片厂全面采购ASML最先进High NA EUV光刻机以扩产高端制程。ASML确认三星、台积电与英特尔已承诺在2028–2030年起量产使用High NA设备，并与ASML签订光罩尺寸升级合作协议，助力降低AI芯片制造成本。","market":"hk","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2041044095.USD","LU0823417653.USD","LU0056508442.USD","LU0541501648.USD","LU1093756325.SGD","OZEM","BK4141","LU0976567544.SGD","LU1069347547.HKD","LU2505996509.AUD","IE0004086264.USD","LU1804176565.USD","IGV","LU0070217475.USD","LU1983299246.USD","LU1150488218.USD","CGDG","LU0950375773.USD","LU2129689431.USD","LU0359202008.SGD","LU0889566641.SGD","LU0124676726.USD","LU0278409577.USD","SG9999013999.USD","LU2125154935.USD","BK4548","LU2087621335.USD","SGXZ57979304.SGD","BK4599","LU0061474960.USD","IE00BLSP4452.SGD","LU0345774391.USD","IE00BHPRN162.USD","LU1718418525.SGD","BK4535","LU0861579265.USD","LU1732800096.USD","LU0823414551.USD","LU2129689514.USD","LU0868494617.USD","IE00B19Z3581.USD","EFA","BK4526","LU2089283258.USD","LU2362541513.USD","LU2543165471.USD","IE00BQXX3C00.GBP","TTEQ","FDTX","LU2458330243.SGD","LU2360108059.USD","LU0868494708.USD","BK4566","SG9999001440.SGD","LU2023250504.SGD","LU2506951958.HKD","AIQ","LU0878005551.USD","LU0289739699.SGD","LU1803068979.SGD","SG9999014575.USD","XLE","BK4201","DDM","LU0130103400.USD","LU0823434583.USD","LU1064131342.USD","BBH","LUMA","LU2491050154.USD","LU1366192091.USD","LU2764262908.HKD","LU0300736062.USD","LU1989772923.USD","LU1585245621.USD","LU1778281490.HKD","FTXL","LU1066053197.SGD","LU2931357623.SGD","LU0345770308.USD","LU0234570918.USD","ADVE","LU0823416689.USD","LU1282649067.USD","QQQA","LU0795875086.SGD","03145","CHPX","LU2242649171.HKD","LU1894683348.USD","LU2430703251.USD","LU0654597011.USD","LEGR","LU2264538146.SGD","LU0545039389.USD","LU0081259029.USD","WEEI","BK4503","LU1868838027.USD","LU1992135472.HKD","LU1935042488.USD","PPH","LU0572939691.SGD","LU0345770993.USD","LU1282649810.SGD","INTW","LU2362540622.SGD","SPTE","BK4570","LU0368265418.SGD","LU1023057109.AUD","LU2211814178.USD","LU0211327993.USD","LU0965509101.SGD","LU2237443549.SGD","LU0476273544.USD","LU0122379950.USD","LU2360032135.SGD","LU0109392836.USD","BK4554","LU1868837565.USD","BK4528","IE00BQXX3F31.USD","LU1974910355.USD","BK5113","BK4007","PXI","IE00BFXG1179.USD","LU2063271972.USD","TRUN","AVEM","LU0238689110.USD","IE000SO60NU8.SGD","BK4097","LU2462611646.USD","SOXX","CHPS","SG9999002232.USD","LU0162691827.USD","LU2896262040.SGD","WQTM","LU0256863811.USD","LU0143863784.USD","LU2244417387.USD","LU0048573561.USD","SG9999000418.SGD","LU2487616109.SGD","LU0070302665.USD","LU1935043536.SGD","LU1046421795.USD","LU0957791311.USD","LU0251132253.USD","IE00BN8TJ469.HKD","IYE","EPAI","LU0345769631.USD","LU0444973449.USD","IXC","IE00BBT3K403.USD","LU1989764748.USD","LU2764263203.CNY","LU0466842654.USD","LU1267930227.SGD","LU0094547139.USD","CRAK","BK4534","BK4516","BLOX","BK4148",".DJI","LU2324357040.USD","LU1917777945.USD","ASIA","INT","LU1791710582.SGD","LU2505996681.GBP","LU0210528500.USD","IE00B7SZL793.SGD","QTUP","LU2473716301.USD","LU1861215975.USD","LU1435385759.SGD","LU2271345857.HKD","LU0738911758.USD","LU0882574055.USD","LU1935042991.SGD","LU0882747503.HKD","LU2102340556.USD","BK4578","LU0553294199.USD","BK4532","LU1815336760.USD","IE00B19Z4B17.USD","LU0742534661.SGD","LU2471134879.HKD","OILT","LU2089984988.USD","LU1582986359.USD","LU0359201612.USD","LU2023251221.USD","LU0965509010.AUD","ASMH","LU0496365809.HKD","BK4023","ERX","LU0274383776.USD","DBEF","LU2360106780.USD","LU1489326972.SGD","IE00BZ1G4Q59.USD","TDIV","IBBQ","IE00B5949003.HKD","LU0314106906.USD","LU0114720955.EUR","LU0143863198.USD","IE00BFXG0V08.USD","PQNT","LU0097036916.USD","LU0149725797.USD","LU1791710400.SGD","CHAT","IE0002141913.USD","LU0795875169.SGD","ORCU","LU0109394709.USD","LU2491049909.HKD","LU0648000940.SGD","CGNG","LU0072461881.USD","LU0208291251.USD","LU0266512127.USD","BK4504","LU0321505439.SGD","LU0157215616.USD","LU0823038988.USD","LU1935043023.USD","RSPG","DRIV","LU0942090050.USD","LU1929549753.HKD","LU0630314457.HKD","LU2108987350.USD","LU0345769128.USD","IFLR","LU2360107168.USD","LU1935042215.USD","IE00BMPRXQ63.HKD","LU2237443622.USD","LU2491050071.SGD","LU0011850046.USD","LU0417517546.SGD","LU0052756011.USD","LU0985489474.SGD","LU2720916845.USD","VDE","LU2357627491.SGD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU0084288322.USD","BIB","LU1150488135.SGD","SMH","CTEX","LU0170899867.USD","LU1712237335.SGD","LU1883866441.USD","BK4170","LU2430703178.SGD","LU2236285917.USD","LU0211328371.USD","LU2592432038.USD","LU1674673428.USD","LU2663582299.SGD","SPWO","HYDR","LU0541502299.USD","LU1674673691.USD","LU2111349929.HKD","LU2148611432.USD","IE00BD6J9T35.USD","LU0068578508.USD","LU2471134796.USD","IE00BZ199S13.USD","LU2357305700.SGD","LU0138981039.USD","AVXC","CNAV","IE00B7SZLL34.SGD","LU0889565916.HKD","LU2750360641.GBP","BK4157","LU1894683264.USD","FENI","BK4575","LU0211331839.USD","LU0345781412.USD","IE00BMPRXN33.USD","LU0868486357.SGD","LU0823039010.USD","IE00BJT1NW94.SGD","LU1201861249.SGD","PJP","LU1571399168.USD","LU2506951875.HKD","OGIG","LU1366333091.USD","LU1323610961.USD","ESIM","LU0077335932.USD","LU0225283273.USD","IE000M9KFDE8.USD","LU1093756168.USD","LU2326559502.SGD","IE000BZT7R73.USD","TEK","LU1023059063.AUD","GNMX","LU0320765992.SGD","LU0058720904.USD","03165","LU1582987597.SGD","LU1003077747.HKD","LU2092937221.SGD","LU0642271901.SGD","IE00B1XK9C88.USD","IE0002270589.USD","LU0128525689.USD","LU0689626769.HKD","LU2089284900.SGD","LU1642822529.SGD","LU1989771016.USD","SG9999004220.SGD","SG9999002224.SGD","LU1720051017.SGD","IEO","LU1066051498.USD","LU0612318385.USD","LU0300736492.USD","SPY","LU2250418816.HKD","IE00B775SV38.USD","IE000WAW04H5.SGD","LU2028103732.USD","IE00BLSP4239.USD","LU1429558221.USD","LU0175139822.USD","LU0154245673.USD","LU0823421416.USD","LU0029874061.USD","LU2471134952.CNY","LU0965508806.USD","EMC","LU1153585028.USD","SG9999014567.USD","LU2272731782.SGD","LU2087625088.SGD","GXPE","SGXZ81514606.USD","LU0289960550.SGD","LU0264606111.USD","BK7095","BK4533","LU0154236417.USD","LU0878004406.USD","LU1057294990.SGD","ILOW","LU2054465674.USD","LU2237443382.USD","BK4538","LU1201861165.SGD","IE0009356076.USD","IE0031619046.USD","IE000MB6IJN5.SGD","DOG","LU2746668461.USD","LU1506573853.SGD","LU2764263039.SGD","BK4121","ORCX","AIS","FENY","LU1074936037.SGD","IEFA","SG9999011175.SGD","IE00BKVL7J92.USD","LU1732799900.SGD","DRLL","LU2602419157.SGD","BK4529","DIG","LU1989764664.SGD","IBB","HK0000304797.USD","LU0267386448.USD","IE00B3M56506.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU2471134523.USD","LU0321505868.SGD","BK4559","IE00B1BXHZ80.USD","IE00B2Q91V27.USD","LU2506952170.USD","IE0004445239.USD","LU0384037296.USD","THNR","LU0683600562.USD","LU2290526834.HKD","ORCL","LU1316542783.SGD","CQTM","LU0788109394.HKD","LU1548497426.USD","ORAC","BK4505","EGGY","LU1823568750.SGD","TINS","LU0433182093.SGD","DIA","WUGI","LU0488056044.USD","MEMX","DBEU","LU0234572021.USD","LU1720051108.HKD","FOTO","LU0348723411.USD","LU0210536198.USD","LU0203345920.USD","LINT","AVSE","BK4213","BK4605","BGIA","TEXU","LU0965509283.SGD","LU0320765489.SGD","IE0004091025.USD","PBE","BK4591","LU0612318971.USD","IE00B4R5TH58.HKD","LU2322448791.USD","LU0158827781.USD","LU0823414478.USD","LU2211815571.USD","DXD","LU2272731865.HKD","LU0211326755.USD","LU1037948897.HKD","LU0719512351.SGD","LU0456854461.SGD","LU2430703095.HKD","BK4608","MEDX","SG9999014542.SGD","LU1037948541.HKD","LU1508157978.USD","LU1211504680.USD","IE00B19Z3B42.SGD","LU2506951792.HKD","SGXZ51526630.SGD","PXE","LU2322448957.HKD","LU0130517989.USD","BK4543","LU0256331488.USD","LU0353189763.USD","LU1868837722.USD","LU2462591277.SGD","LU0359201885.HKD","LU1691799644.USD","LU0310800965.SGD","FTXN","IE0000B7K699.USD","BK4527","LU1861220033.SGD","LU0320765646.SGD","SG9999015358.SGD","BK4588","NVS","INYY","LU0353189680.USD","LU2954938101.SGD","BK4550","IE0034235303.USD","EMM","IGE","ORCS","SG9999001176.SGD","LU2237443978.SGD","IE00B3CCJ963.GBP","LU1582987324.SGD","LU1582986433.USD","LU0889565833.HKD","GNOM","CGGO","HBMX","LU2265009873.SGD","SG9999015341.SGD","TBXU","LU1430594728.SGD","LU1061106388.HKD","LU1934455194.USD","HK0000304805.HKD","LU0572940350.SGD","SG9999003800.SGD","IE00B3S45H60.SGD","LU2746668974.SGD","LU0431992006.USD","LU2294711713.HKD","LU0648001328.SGD","LU1048588211.SGD","LU2506952097.USD","SG9999001424.SGD","SDOW","LU0053666078.USD","BK4602","UDOW","LU0143551892.USD","LU0154245756.USD","CGIC","TNGY","SG9999014559.SGD","LU1934455277.USD","LU0859254822.USD","LU0198837287.USD","LU1815333072.USD","LU2498475776.HKD","IE0009355771.USD","LU0477156953.USD","LU1934455863.HKD","BK4581","LU0082616367.USD","LU2362541273.HKD","LU2860962120.EUR","LU2999663052.SGD","LU1989772840.SGD","LU2242646821.SGD","BK4592","LU2272731600.USD","LU2242652126.USD","LU0122376428.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","LU2237957902.USD","IE00BKPKM429.USD","CNEQ","IE00BQXX3D17.EUR","IE00BJJMRZ35.SGD","LU0957808578.USD","XNTK","LU0323591593.USD","LU2112291526.USD","LU0792757196.USD","LU2347655156.SGD","SG9999001176.USD","LU1992135399.USD","LU2133065610.SGD","SPRX","LU1430597077.USD","LU0203347892.USD","FFGX","LU0787776722.HKD","IE00BYQQ9H92.USD","LU0187121727.USD","INTC","LU1267930490.SGD","FCG","LU0661504455.SGD","LU1235294995.USD","LU2129689605.HKD","BK4612","LU0980610538.SGD","BK4082","LU1162221912.USD","BAI","LU0823421333.USD","LU1852331112.SGD","LU1623119135.USD","LU1734074674.USD","LU0949170772.SGD","LU0048584097.USD","IE00BGHQF524.EUR","LU0345774631.USD","LU0251142724.SGD","LU0266512473.USD","LU0823417737.USD","SG9999002521.SGD","IE00BMPRXR70.SGD","BK4512","LU0072462343.USD","LU0128526141.USD","GSID","BK4147","UMMA","BK4515","LU0823434740.USD","LU0098860793.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU2249611893.SGD","LU0158827948.USD","BK7104","LU2458330169.SGD","LU1035773651.USD","IE00BSNM7G36.USD","BK4579","LU2357125470.USD","LU1988902786.USD","LU2089985449.USD","BK4139","KNOW","LU0444971666.USD","LU0211326839.USD","LU2298321311.HKD","LU2750360997.AUD","CORO","LU1839511570.USD","LU2237957811.SGD","LU2468319806.SGD","LU0528227936.USD","LU1291159041.SGD","LU0130102774.USD","LU0266013472.USD","LU0251131958.USD","BK4138","BK4585","CWI","LU0912757837.SGD","LU0310799852.SGD","LU0345780950.USD","LU0878866978.SGD","ORCZ","IE00B5TLWC47.USD","IE000F7OJYX1.SGD","IE00B66KJ199.SGD","LU2247934214.USD","LU0316494557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665215326","title":"諾華試驗受挫且BMO下調評級，安進股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2665215326","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665215326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859661,"startTime":"0","endTime":"0","summary":"BUZZ-诺华试验受挫且BMO下调评级，安进股价下跌9月8日-** 安进公司（AMGN.O）股价盘前下跌4.8%，至416美元** 诺华公司（NOVN.S）的降胆固醇药物在一项备受关注的研究中未能达标，这引发了市场对安进公司（Amgen）实验性降胆固醇药物olpasiran的担忧 (link)** 摩根大通分析师表示，诺华的pelacarsen研究结果降低了市场对安进olpasiran的预期，而该","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4139","IE00B4R5TH58.HKD","BK4599","LU1057294990.SGD","LU0058720904.USD","LU1023059063.AUD","LU0889565916.HKD","TBXU","AMGN","IE00B2B36J28.USD","LU2468319806.SGD","BK4585","PJP","SG9999001440.SGD","LU1983299246.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0868494617.USD","LU0320765992.SGD","PBE","BK4588","BIB","LU1061106388.HKD","IBBQ","BBH","LU0122379950.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4566","LU2242652126.USD","IBB","IE00BJJMRZ35.SGD","BK4533","BK4581","LU2242646821.SGD","LU2112291526.USD","LU2089984988.USD","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176595225","title":"盤前異動：安進、耐克、Bloom Energy 等個股受關注","url":"https://stock-news.laohu8.com/highlight/detail?id=1176595225","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176595225?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:10","pubTimestamp":1788858632,"startTime":"0","endTime":"0","summary":"安进：这家生物科技巨头、道琼斯指数的重要权重股，其盘前股价重挫逾5%。此前，瑞士制药商诺华宣称，其一款实验性药物在晚期临床试验中未能有效降低心血管风险。安进与礼来目前正在各自研发竞品疗法以应对挑战。消息传出后，诺华在欧股市场大跌10%，礼来股价亦小幅走低。Bloom Energy：这家燃料电池制造商可谓利好连连。受此提振，其盘前股价上扬4%。游戏驿站定于今日美股收盘后发布财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07399","IE00BJT1NW94.SGD","MSTW","LU2098885051.SGD","CRPT","HOOX","BK4599","BK4532","PJP","BPAY","MSST","NVS","CONL","SMST","LU0823414478.USD","HOOZ","COII","ROBN","07799","FIAT","IE00BJJMRZ35.SGD","LU0708994859.HKD","LU2360107671.USD","LU0122379950.USD","MSTK","BBH","LU0058720904.USD","IMST","OWNB","LMI3.UK","BK4561","COIO","BK4533","EGGY","BK4596","LU1057294990.SGD","LU1303367103.USD","LU1861559042.SGD","BK4182","CONY","GMEC","CONX","HODU","LU1267930813.SGD","LU0957808578.USD","BK4127","FDIG","IBLC","07311","MSTZ","LU2249611893.SGD","LU1988902786.USD","LU0070302665.USD","09711","LU2089984988.USD","LU0052756011.USD","APED","BK4541","BK4539","BK4581","LU1861220207.SGD","BK4516","VTWG","MSTR","BK4600","LU0211331839.USD","ICLN","GMEY","IE0009355771.USD","LU0889566641.SGD","BK4146","COIG","CONI","LU0109394709.USD","LU0823414551.USD","LU0868494617.USD","LU2468319806.SGD","IGME","LU0476273544.USD","LU0208291251.USD","NKE","PPH","COYY","09399","LU0128525689.USD","LU0128525929.USD","3SMI.UK","BE","BK4566","LU0289739699.SGD","TBXU","BK4007","SIMS","04332","ICOI","LU1064131342.USD","UPGR","LU2264538146.SGD","LU1642822529.SGD","LU1267930227.SGD","HOOD","MSOO","BK4139","MSTY.UK","BK4558","BK4578","HOOI","BEZ","LU2357125470.USD","MSTP","ZAP","LU0029864427.USD","COIA","IE00BFTCPJ56.SGD","LU2506951792.HKD","SMI3.UK","MSTX","HOYY","LU2543165471.USD","LU1571399168.USD","BITQ","GME","MSDD","IE0009354923.USD","BK4588","HOOW","LU0310800379.SGD","IE00B2B36J28.USD","AMGN","IE0002141913.USD","HOOG","MTYY","BK4585","BK4112","BEX","IE00BFXG0V08.USD","MST","FINX","BLCK","IE00B4R5TH58.HKD","LU1267930573.SGD","LU0823411888.USD","DAPP","LU0889565916.HKD","LU1861558580.USD","BEG","07711","WNTR","BK4554","IE00BYQQ9H92.USD","09799","BK4534","COIN","BK4577","LU0444973449.USD","HOOY","MEDX","MSTU","COIX","CTEC","HOOC","IAI","BK4023","LU2112291526.USD","VCLN","BK4595","LU0320765992.SGD","BKCH","LU0320765489.SGD","LU1815336760.USD","LU1983299246.USD","BK4547","BK4076","LU1061106388.HKD","09311","BK4535","HOII","LU0786609619.USD","BEC","IBBQ","STYL","LU0792757196.USD","SG9999001440.SGD","COIW","IBAT","PBE","LU2294711713.HKD","GMEU","FRNW","LU1861217088.USD","BK4551","3LMI.UK","LU0310800965.SGD","MSTC","WATS","MSTY","CNRG","LU0444971666.USD","SMOG","MSII","LU2242646821.SGD","IBB","BIB","LU1023059063.AUD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326953","title":"美股異動｜安進盤前跌5.4%，諾華同靶點藥物III期臨床失敗，Lp(a)賽道遭重創","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326953","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326953?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858422,"startTime":"0","endTime":"0","summary":"消息面上，诺华于9月4日公布，其与Ionis联合开发的降脂药物Pelacarsen，在名为LpHORIZON的III期临床试验中未能达到主要终点。诺华的Pelacarsen是全球首个针对Lp靶点进行心血管结局验证的III期药物。因此，市场担忧情绪蔓延到了同样在开发Lp药物的安进身上。多家分析机构认为，诺华的失败削弱了但并未完全推翻Lp这一靶点的可行性。安进后续公布的Olpasiran完整试验数据，将成为判断该靶点未来走向的关键。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["PJP","SG9999001440.SGD","LU0868494617.USD","LU0320765489.SGD","LU0320765992.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","PPH","IBBQ","LU2242652126.USD","BK4578","LU0211331839.USD","LU2112291526.USD","TBXU","BK4139","IBB","LU2089984988.USD","LU0208291251.USD","BK4566","BBH","LU1983299246.USD","LU1571399168.USD","LU0109394709.USD","MEDX","PBE","LU2468319806.SGD","BK4007","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4581","AMGN","BIB","IE00B4R5TH58.HKD","NVS","BK4599","IE00BJT1NW94.SGD","LU0122379950.USD","LU0289739699.SGD","BK4532","LU0058720904.USD","LU1061106388.HKD","BK4534","LU1023059063.AUD","BK4533","BK4585","BK4588","LU0889565916.HKD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":198,"code":"91000000","status":"200"}]}}